Optimal control analysis of a leukemia model under imatinib treatment

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Mathematics and Computers in Simulation

• Publication date

  2016-03-01

• Fields of study

  Medicine, Mathematics, Computer Science

• Identifiers
  DOI 10.1016/j.matcom.2015.03.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival.

  2012cited by this paper
• Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy

  2011cited by this paper
• Role of symmetric and asymmetric division of stem cells in developing drug resistance

  2010cited by this paper
• A Model of Oscillatory Blood Cell Counts in Chronic Myelogenous Leukaemia

  2010cited by this paper
• Optimal control for resistance and suboptimal response in CML.

  2010cited by this paper
• Modeling of replicative senescence in hematopoietic development

  2009cited by this paper
• Optimal control problems with delays in state and control variables subject to mixed control–state constraints

  2009cited by this paper
• A Mathematical Study of the Hematopoiesis Process with Applications to Chronic Myelogenous Leukemia

  2009cited by this paper
• Numerical Solution of Optimal Control Problems with Constant Control Delays

  2008cited by this paper
• Dynamics and Potential Impact of the Immune Response to Chronic Myelogenous Leukemia

  2008cited by this paper
• Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls.

  2007cited by this paper
• Optimal control of treatment in a mathematical model of chronic myelogenous leukemia.

  2007cited by this paper
• High frequency spikes in long period blood cell oscillations

  2006cited by this paper
• Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division.

  2006cited by this paper
• Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications

  2006cited by this paper
• Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate

  2005cited by this paper
• Long Period Oscillations in a G0 Model of Hematopoietic Stem Cells

  2005cited by this paper
• Dynamics of chronic myeloid leukaemia

  2005cited by this paper
• Drug resistance in cancer: principles of emergence and prevention.

  2005cited by this paper
• Stability and Hopf bifurcation in a mathematical model of pluripotent stem cell dynamics

  2005cited by this paper
• Drug resistance in cancer chemotherapy as an optimal control problem

  2005cited by this paper
• A mathematical model of hematopoiesis--I. Periodic chronic myelogenous leukemia.

  2005cited by this paper
• A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction.

  2004cited by this paper
• Dynamics of cancer progression

  2004cited by this paper
• Bifurcations in a white-blood-cell production model.

  2004cited by this paper
• Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant

  2004cited by this paper
• Contribution to the study of periodic chronic myelogenous leukemia.

  2004cited by this paper
• OPTIMAL CONTROL APPLIED TO IMMUNOTHERAPY

  2003cited by this paper
• OPTIMAL CONTROL FOR A CLASS OF COMPARTMENTAL MODELS IN CANCER CHEMOTHERAPY

  2003cited by this paper
• Chronic myeloid leukemia--advances in biology and new approaches to treatment.

  2003cited by this paper
• Relaxation Oscillations in a Class of Delay Differential Equations

  2002cited by this paper
• Optimal control of innate immune response

  2002cited by this paper
• Two genetic hits (more or less) to cancer

  2001cited by this paper
• Cell kinetic status of haematopoietic stem cells

  2001cited by this paper
• CHRONIC MYELOGENOUS LEUKAEMIA

  2000cited by this paper
• The molecular biology of chronic myeloid leukemia.

  2000cited by this paper
• Modeling complex neutrophil dynamics in the grey collie.

  2000cited by this paper
• Gut instincts: thoughts on intestinal epithelial stem cells.

  2000cited by this paper
• Chronic myeloid leukemia.

  1999cited by this paper
• Hematopoietic model with moving boundary condition and state dependent delay: applications in erythropoiesis.

  1998cited by this paper
• A Model for the Regulation of Mammalian Platelet Production a

  1987cited by this paper
• Mutation and cancer: a model for human carcinogenesis.

  1981cited by this paper
• Oscillation and chaos in physiological control systems.

  1977cited by this paper

• RedFox optimized control designs for acute leukemia therapy

  2026cites this paper
• Optimized Integral Super-Twisting Sliding Mode Control for Acute Leukemia Therapy

  2025cites this paper
• Chemo and immunotherapy effects on stability regions of tumor models

  2024cites this paper
• Adaptive boundary layer double integral sliding mode controller design for leukemia therapy

  2023cites this paper
• Adaptive terminal and supertwisting sliding mode controllers for acute Leukemia therapy

  2022cites this paper
• Computational systems biology in disease modeling and control, review and perspectives

  2022cites this paper
• Progression, detection and remission: evolution of chronic myeloid leukemia using a three-stage probabilistic model

  2022cites this paper
• A systematic review of modeling and simulation approaches in designing targeted treatment technologies for Leukemia Cancer in low and middle income countries.

  2021cites this paper
• An intelligent control strategy for cancer cells reduction in patients with chronic myelogenous leukaemia using the reinforcement learning and considering side effects of the drug

  2020cites this paper
• Double Integral sliding mode control of Leukemia Therapy

  2020cites this paper
• Mathematical analysis and global dynamics for a time-delayed Chronic Myeloid Leukemia model with treatment

  2020cites this paper
• A quantitative study on the role of TKI combined with Wnt/β-catenin signaling and IFN-α in the treatment of CML through deterministic and stochastic approaches

  2019cites this paper
• Optimal sliding mode control of drug delivery in cancerous tumour chemotherapy considering the obesity effects.

  2018cites this paper
• Leukosis Mathematical Model

  2018cites this paper
• Optimization of Combined Leukemia Therapy by Finite-Dimensional Optimal Control Modeling

  2017cites this paper
• Optimization of Combined Leukemia Therapy by Finite-Dimensional Optimal Control Modeling

  2017cites this paper
• Sensitive determination of anticancer drug imatinib in spiked human urine samples by differential pulse voltammetry on anodically pretreated boron-doped diamond electrode

  2016cites this paper
• Optimum Experimental Design for Patient Specific Mathematical Leukopenia Models

  2016cites this paper
• Numerical study on the complete blood cell sorting using particle tracing and dielectrophoresis in a microfluidic device

  2016cites this paper
• Study on the Optimal Control Policy of Rural Medical Insurance System with High Satisfaction Degree for the Aged

  2016cites this paper